Human papillomavirus distribution in cervical tissues of different morphology as determined by hybrid capture assay and PCR

被引:31
作者
Nindl, I
Greinke, C
Zahm, DM
Stockfleth, E
Hoyer, H
Schneider, A
机构
[1] CHRISTIAN ALBRECHTS UNIV KIEL,DEPT DERMATOL,D-2300 KIEL,GERMANY
[2] UNIV JENA,DEPT MED STAT COMP SCI & DOCUMENTAT,D-6900 JENA,GERMANY
关键词
human papillomavirus (HPV); hybrid capture assay (HCA); polymerase chain reaction (PCR); virus load; HPV distribution;
D O I
10.1097/00004347-199707000-00002
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Distribution of various types of genital human Papillomavirus (HPV) in smears from histologically classified cervical lesions was determined by hybrid capture assay (HCA) and was compared with a polymerase chain reaction (PCR) system using general primers (GP) in first and type specific primers (TS) in a second step. The overall agreement of high-risk HPV by HCA and the more sensitive GP/TS PCR was 80.6% (204 of 253, kappa value 0.6). Human Papillomavirus frequency by GP/TS PCR was 14-20% higher compared with HCA (p = 0.02-0.004) independent of morphology. Only one sample was positive by HCA and negative by GP/TS PCR. A significantly higher frequency was found using HCA and GP/TS PCR in smears from histologically proven cervical intraepithelial lesions (CIN) II/III compared with CIN I, tissues with minimal changes (metaplasia, cervicitis, or lack of glycogenization), or normal morphology (61% and 81% vs 8-15% and 24-34%, p less than or equal to 0.001). Semi-quantitative estimate of HPV DNA copies by CIP-PCR coincided with estimated virus load by quantitative HCA and was significantly higher in patients with CIN II/III compared with CIN I (p < 0.001). Thus, the GP-PCR may be used to monitor the amount of HPV DNA copies in clinical samples. A direct correlation between morphologic changes and HPV detection as well as virus load was found by HCA and the more sensitive GP/TS PCR.
引用
收藏
页码:197 / 204
页数:8
相关论文
共 36 条
[21]  
MELKERT PWJ, 1993, INT J CANCER, V53, P919, DOI 10.1002/ijc.2910530609
[22]   BEHAVIOR OF MILD CERVICAL DYSPLASIA DURING LONG-TERM FOLLOW-UP [J].
NASIELL, K ;
ROGER, V ;
NASIELL, M .
OBSTETRICS AND GYNECOLOGY, 1986, 67 (05) :665-669
[23]  
OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186
[24]   THE PRESENCE OF PERSISTENT HIGH-RISK HPV GENOTYPES IN DYSPLASTIC CERVICAL LESIONS IS ASSOCIATED WITH PROGRESSIVE DISEASE - NATURAL-HISTORY UP TO 36 MONTHS [J].
REMMINK, AJ ;
WALBOOMERS, JMM ;
HELMERHORST, TJM ;
VOORHORST, FJ ;
ROZENDAAL, L ;
RISSE, EKJ ;
MEIJER, CJLM ;
KENEMANS, P .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (03) :306-311
[25]  
Richart R M, 1973, Pathol Annu, V8, P301
[26]  
RICHART RM, 1990, OBSTET GYNECOL, V75, P131
[27]   RECENT PROGRESS IN DEFINING THE EPIDEMIOLOGY OF HUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL NEOPLASIA [J].
SCHIFFMAN, MH .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (06) :394-398
[28]   Screening for cervical intraepithelial neoplasia grade 2/3: Validity of cytologic study, cervicography, and human papillomavirus detection [J].
Schneider, A ;
Zahm, DM ;
Kirchmayr, R ;
Schneider, VL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (05) :1534-1541
[29]   INTRODUCTION OF A FAST AND SENSITIVE FLUORESCENT IN-SITU HYBRIDIZATION METHOD FOR SINGLE-COPY DETECTION OF HUMAN PAPILLOMAVIRUS (HPV) GENOME [J].
SIADATPAJOUH, M ;
AYSCUE, AH ;
PERIASAMY, A ;
HERMAN, B .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1994, 42 (11) :1503-1512
[30]   INTERMETHOD VARIATION IN DETECTION OF HUMAN PAPILLOMAVIRUS DNA IN CERVICAL SMEARS [J].
SMITS, HL ;
BOLLEN, LJM ;
TJONGAHUNG, SP ;
VONK, J ;
VANDERVELDEN, J ;
TENKATE, FJW ;
KAAN, JA ;
MOL, BW ;
TERSCHEGGET, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (10) :2631-2636